• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用和拮抗微小RNA调控以用于治疗和实验应用。

Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications.

作者信息

Brown Brian D, Naldini Luigi

机构信息

Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, 1425 Madison Avenue, BOX 1498, New York, New York 10029, USA.

出版信息

Nat Rev Genet. 2009 Aug;10(8):578-85. doi: 10.1038/nrg2628.

DOI:10.1038/nrg2628
PMID:19609263
Abstract

New technologies are emerging that utilize artificial microRNA (miRNA) target sites to exploit or inhibit endogenous miRNA regulation. This approach has been used to improve cell-specific targeting for gene and stem cell therapy studies and for animal transgenics, and also to reduce the toxicity of oncolytic viruses and to attenuate viral vaccines. Artificial targets have also been used to sponge or decoy miRNAs as a way to study their functions. This article considers the benefits of this approach and design considerations for future studies.

摘要

利用人工微小RNA(miRNA)靶位点来开发或抑制内源性miRNA调控的新技术正在不断涌现。这种方法已被用于改善基因和干细胞治疗研究以及动物转基因研究中的细胞特异性靶向,还可降低溶瘤病毒的毒性并减弱病毒疫苗的效力。人工靶标也被用于吸附或诱捕miRNA,以此来研究它们的功能。本文探讨了这种方法的优势以及未来研究的设计考量。

相似文献

1
Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications.利用和拮抗微小RNA调控以用于治疗和实验应用。
Nat Rev Genet. 2009 Aug;10(8):578-85. doi: 10.1038/nrg2628.
2
MicroRNAs as targets for antisense-based therapeutics.作为基于反义技术疗法靶点的微小RNA
Expert Opin Biol Ther. 2008 Jan;8(1):59-81. doi: 10.1517/14712598.8.1.59.
3
microRNA inhibitors: Natural and artificial sequestration of microRNA.microRNA 抑制剂:microRNA 的天然和人工封闭。
Cancer Lett. 2017 Oct 28;407:139-147. doi: 10.1016/j.canlet.2017.05.025. Epub 2017 Jun 8.
4
The promise of microRNA replacement therapy.微小RNA替代疗法的前景。
Cancer Res. 2010 Sep 15;70(18):7027-30. doi: 10.1158/0008-5472.CAN-10-2010. Epub 2010 Aug 31.
5
MicroRNAs and oncolytic viruses.微小 RNA 与溶瘤病毒。
Curr Opin Virol. 2015 Aug;13:40-8. doi: 10.1016/j.coviro.2015.03.007. Epub 2015 Apr 13.
6
microRNAs as pharmacological targets in cancer.microRNAs 作为癌症的治疗靶点。
Pharmacol Res. 2013 Sep;75:3-14. doi: 10.1016/j.phrs.2013.03.006. Epub 2013 Mar 25.
7
MicroRNAs as therapeutic targets in chemoresistance.微小RNA作为化疗耐药中的治疗靶点。
Drug Resist Updat. 2013 Jul-Nov;16(3-5):47-59. doi: 10.1016/j.drup.2013.05.001. Epub 2013 Jun 10.
8
Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs.通过抑制致癌 miRNA 开发新型治疗药物。
Int J Mol Sci. 2017 Dec 27;19(1):65. doi: 10.3390/ijms19010065.
9
Suppression of microRNAs by dual-targeting and clustered Tough Decoy inhibitors.双靶点和聚集 Tough Decoy 抑制剂对 microRNAs 的抑制作用。
RNA Biol. 2013 Mar;10(3):406-14. doi: 10.4161/rna.23543. Epub 2013 Jan 16.
10
MicroRNAs-based Therapy: A Novel and Promising Strategy for Cancer Treatment.基于微小核糖核酸的疗法:一种用于癌症治疗的新颖且有前景的策略。
Microrna. 2017 Aug 16;6(2):102-109. doi: 10.2174/2211536606666170710183039.

引用本文的文献

1
Peritoneal fibrosis: from pathophysiological mechanism to medicine.腹膜纤维化:从病理生理机制到医学
Front Physiol. 2024 Sep 4;15:1438952. doi: 10.3389/fphys.2024.1438952. eCollection 2024.
2
704/DNA vaccines leverage cytoplasmic DNA stimulation to promote anti-HIV neutralizing antibody production in mice and strong immune response against alpha-fetoprotein in non-human primates.704/DNA疫苗利用细胞质DNA刺激,促进小鼠体内抗HIV中和抗体的产生,并在非人灵长类动物中引发针对甲胎蛋白的强烈免疫反应。
Mol Ther Nucleic Acids. 2023 May 4;32:743-757. doi: 10.1016/j.omtn.2023.04.029. eCollection 2023 Jun 13.
3
The Host Non-Coding RNA Response to Alphavirus Infection.

本文引用的文献

1
A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.一种具有多效性作用的微小RNA,即miR-31,可抑制乳腺癌转移。
Cell. 2009 Jun 12;137(6):1032-46. doi: 10.1016/j.cell.2009.03.047.
2
MicroRNA-mediated species-specific attenuation of influenza A virus.微小RNA介导的甲型流感病毒种属特异性衰减
Nat Biotechnol. 2009 Jun;27(6):572-6. doi: 10.1038/nbt.1542. Epub 2009 May 31.
3
Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells.
宿主非编码 RNA 对甲病毒感染的反应。
Viruses. 2023 Feb 18;15(2):562. doi: 10.3390/v15020562.
4
Therapeutic Implications of microRNAs in Depressive Disorders: A Review.microRNAs 在抑郁障碍中的治疗意义:综述。
Int J Mol Sci. 2022 Nov 4;23(21):13530. doi: 10.3390/ijms232113530.
5
Exosome Carrier Effects; Resistance to Digestion in Phagolysosomes May Assist Transfers to Targeted Cells; II Transfers of miRNAs Are Better Analyzed via Systems Approach as They Do Not Fit Conventional Reductionist Stoichiometric Concepts.外泌体载体效应;在吞噬溶酶体中抵抗消化可能有助于向靶细胞转移;二 通过系统方法分析 miRNA 的转移效果更好,因为它们不符合传统的还原论计量概念。
Int J Mol Sci. 2022 May 31;23(11):6192. doi: 10.3390/ijms23116192.
6
MicroRNA-365a/b-3p as a Potential Biomarker for Hypertrophic Scars.微小 RNA-365a/b-3p 作为肥厚性瘢痕的潜在生物标志物。
Int J Mol Sci. 2022 May 30;23(11):6117. doi: 10.3390/ijms23116117.
7
Therapeutic Metabolic Reprograming Using microRNAs: From Cancer to HIV Infection.治疗代谢重编程的 microRNAs:从癌症到 HIV 感染。
Genes (Basel). 2022 Jan 29;13(2):273. doi: 10.3390/genes13020273.
8
CRISPR Editing Enables Consequential Tag-Activated MicroRNA-Mediated Endogene Deactivation.CRISPR 编辑可实现后果性标签激活 miRNA 介导的内源性失活。
Int J Mol Sci. 2022 Jan 19;23(3):1082. doi: 10.3390/ijms23031082.
9
MiR-148b-3p Regulates the Expression of DTYMK to Drive Hepatocellular Carcinoma Cell Proliferation and Metastasis.MiR-148b-3p通过调控DTYMK的表达促进肝癌细胞增殖和转移。
Front Oncol. 2021 Dec 24;11:625566. doi: 10.3389/fonc.2021.625566. eCollection 2021.
10
miRNA-mediated control of exogenous during mesenchymal-epithelial transition increases measles vector reprogramming efficiency.在间充质-上皮转化过程中,微小RNA介导的对外源物质的调控可提高麻疹病毒载体重编程效率。
Mol Ther Methods Clin Dev. 2021 Nov 29;24:48-61. doi: 10.1016/j.omtm.2021.11.012. eCollection 2022 Mar 10.
利用组织特异性微小RNA来控制野生型腺病毒的病理学特征,同时不削弱其杀死癌细胞的能力。
PLoS Pathog. 2009 May;5(5):e1000440. doi: 10.1371/journal.ppat.1000440. Epub 2009 May 22.
4
A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships.肿瘤浸润性表达Tie2的单核细胞、血液“驻留”单核细胞和胚胎巨噬细胞共有的一个独特基因特征表明它们具有共同的功能和发育关系。
Blood. 2009 Jul 23;114(4):901-14. doi: 10.1182/blood-2009-01-200931. Epub 2009 Apr 21.
5
Redefining microRNA targets.重新定义微小RNA靶点。
Curr Biol. 2009 May 26;19(10):870-3. doi: 10.1016/j.cub.2009.03.059. Epub 2009 Apr 16.
6
Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells.表达高效RNA诱饵的载体可在哺乳动物细胞中实现对特定微小RNA活性的长期抑制。
Nucleic Acids Res. 2009 Apr;37(6):e43. doi: 10.1093/nar/gkp040. Epub 2009 Feb 17.
7
Effect of tissue-specific promoters and microRNA recognition elements on stability of transgene expression after hydrodynamic naked plasmid DNA delivery.组织特异性启动子和微小RNA识别元件对水动力法裸质粒DNA递送后转基因表达稳定性的影响。
Hum Gene Ther. 2009 Apr;20(4):374-88. doi: 10.1089/hum.2008.088.
8
MicroRNAs: target recognition and regulatory functions.微小RNA:靶标识别与调控功能
Cell. 2009 Jan 23;136(2):215-33. doi: 10.1016/j.cell.2009.01.002.
9
Biogenesis of small RNAs in animals.动物中小RNA的生物合成
Nat Rev Mol Cell Biol. 2009 Feb;10(2):126-39. doi: 10.1038/nrm2632.
10
MicroRNAs and the regulation of vector tropism.微小RNA与载体嗜性的调控
Mol Ther. 2009 Mar;17(3):409-16. doi: 10.1038/mt.2008.288. Epub 2008 Dec 23.